| Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies D Alfaiate, S Clément, D Gomes, N Goossens, F Negro Journal of hepatology 73 (3), 533-539, 2020 | 150 | 2020 |
| A review on hepatitis D: From virology to new therapies N Mentha, S Clément, F Negro, D Alfaiate Journal of advanced research 17, 3-15, 2019 | 129 | 2019 |
| HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes D Alfaiate, J Lucifora, N Abeywickrama-Samarakoon, M Michelet, ... Antiviral research 136, 19-31, 2016 | 92 | 2016 |
| Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options D Alfaiate, P Dény, D Durantel Antiviral research 122, 112-129, 2015 | 79 | 2015 |
| Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic … NP Komas, S Ghosh, M Abdou-Chekaraou, P Pradat, N Al Hawajri, ... PLOS Neglected Tropical Diseases 12 (4), e0006377, 2018 | 31 | 2018 |
| Hepatitis Delta Virus histone mimicry drives the recruitment of chromatin remodelers for viral RNA replication N Abeywickrama-Samarakoon, JC Cortay, C Sureau, S Müller, D Alfaiate, ... Nature Communications 11 (1), 419, 2020 | 24 | 2020 |
| Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 Y Merad, A Gaymard, L Cotte, T Perpoint, D Alfaiate, M Godinot, A Becker, ... Eurosurveillance 27 (50), 2200882, 2022 | 16 | 2022 |
| Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays A Bal, MA Trabaud, JB Fassier, M Rabilloud, K Saker, ... Clinical Microbiology and Infection 27 (6), 933-935, 2021 | 15 | 2021 |
| Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and-independent mechanisms J Lucifora, D Alfaiate, C Pons, M Michelet, R Ramirez, F Fusil, F Amirache, ... Journal of Hepatology 78 (5), 958-970, 2023 | 12 | 2023 |
| Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects K Saker, B Pozzetto, V Escuret, V Pitiot, A Massardier-Pilonchéry, ... Journal of Clinical Virology 152, 105169, 2022 | 11 | 2022 |
| Specific detection of memory T‐cells in COVID‐19 patients using standardized whole‐blood Interferon gammarelease assay W Mouton, C Compagnon, K Saker, S Daniel, S Djebali, X Lacoux, ... European Journal of Immunology 51 (12), 3239-3242, 2021 | 10 | 2021 |
| Correction: IL6 inhibits HBV transcription by targeting the epigenetic control of the nuclear cccDNA minichromosome GA Palumbo, C Scisciani, N Pediconi, L Lupacchini, D Alfaiate, ... Plos one 10 (12), e0145555, 2015 | 8 | 2015 |
| Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro M Michelet, D Alfaiate, B Chardès, C Pons, S Faure-Dupuy, T Engleitner, ... JHEP reports 4 (3), 100415, 2022 | 7 | 2022 |
| Efficacy and safety of treatment with bulevirtide in chronic hepatitis delta: preliminary results of the real life ANRS HD EP01 buledelta cohort F Zoulim, C Fougerou, RM Dominique, S Metivier, V De Ledinghen, ... Hepatology 76 (Supp 1), S221-S223, 2022 | 6 | 2022 |
| Nucleic acid polymers: much-needed hope for hepatitis D? D Alfaiate, F Negro The Lancet Gastroenterology & Hepatology 2 (12), 841-842, 2017 | 5 | 2017 |
| du génome du virus de l’hépatite delta N Abeywickrama-Samarakoon, JC Cortay, C Sureau, D Alfaiate, ... médecine/sciences 34, 833-41, 2018 | 4 | 2018 |
| Model of HBV/HDV super-infection to study mechanisms of viral interplay and antivirals: 1746 D Alfaiate, NA Abeywickrama-Samarakoon, B Testoni, J Lucifora, ... Hepatology 60, 1038A, 2014 | 2 | 2014 |
| The impact of late presentation: analysis of a cohort of 313 Portuguese patients D Alfaiate, AC Miranda, J Rijo, D Fernandes, F Borges, H Farinha, ... Journal of the International AIDS Society 13, 1-1, 2010 | 2 | 2010 |
| ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance D Gomes, C Sobolewski, S Conzelmann, T Schaer, E Lefai, D Alfaiate, ... Scientific Reports 13 (1), 6767, 2023 | 1 | 2023 |
| Réplication du génome du virus de l’hépatite delta: un rôle pour la petite protéine delta S-HDAg N Abeywickrama-Samarakoon, JC Cortay, C Sureau, D Alfaiate, ... médecine/sciences 34 (10), 833-841, 2018 | 1 | 2018 |
